Literature DB >> 1801875

Multicenter vs single center phase II evaluation of 4'-iodo-4'-deoxydoxorubicin in advanced breast cancer.

G Schwartsmann, H M Pinedo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801875     DOI: 10.1093/oxfordjournals.annonc.a057845

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life.

Authors:  C J Twelves; N A Dobbs; M A Lawrence; A J Ramirez; M Summerhayes; M A Richards; K E Towlson; R D Rubens
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.